Alpha DNA Investment Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-52,244
Closed -$486K 195
2024
Q2
$486K Buy
+52,244
New +$486K 0.19% 109